Herpes simplex virus mediated gene transfer to primate ocular tissues

Experimental Eye Research

Volumn 69, Issue 4, 1999, Pages 385-395

  Liu, Xuyang ^a   Brandt, Curtis R ^a,b   Gabelt, B'Ann T ^a   Bryar, Paul J ^a   Smith, Morton E ^a   Kaufman, Paul L ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Ciliary epithelium; Ciliary muscle; Cynomolgus monkey; Gene therapy; Gene transfer; Herpes simplex virus type 1; LacZ; Retinal ganglion cells; Ribonucleotide reductase mutant; Trabecular meshwork; galactosidase

Indexed keywords

BETA GALACTOSIDASE; MUTANT PROTEIN; RIBONUCLEOTIDE REDUCTASE;

ANIMAL TISSUE; ARTICLE; CELLULAR DISTRIBUTION; ENZYME ACTIVITY; EYE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSFECTION; HERPES SIMPLEX VIRUS 1; HISTOCHEMISTRY; MONKEY; NONHUMAN; PRIORITY JOURNAL; RETINA GANGLION CELL; TRABECULAR MESHWORK;

EID: 0032885965     PISSN: 00144835     EISSN: None     Source Type: Journal    
DOI: 10.1006/exer.1999.0711     Document Type: Article

References (50)

1. Abraham N. G., da Silva J. L., Lavrovsky Y., Stoltz R. A., Kappas A., Dunn M. W., Schwartzman M. L. Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissue. Invest. Ophthalmol. Vis. Sci. 36:1995;2202-2210.
2. Ali R. R., Reichel M. B., Thrasher A. J., Levinsky R. J., Kinnon C., Kanuga N., Hunt D. M., Bhattacharya S. S. Gene transfer into the mouse retina mediated by an adeno-associated viral vector. Hum. Mol. Genetics. 5:1996;591-594.
3. Ali R. R., Reichel M. B., De Alwis M., Kanuga N., Kinnon C., Levinsky R. J., Hunt D. M., Bhattacharya S. S., Thrasher A. J. Adeno-associated virus gene transfer to mouse retina. Hum. Gene Ther. 9:1998;81-86.
4. Bárány E. H. Simultaneous measurement of changing intraocular pressure and outflow facility in the vervet monkey by constant pressure infusion. Invest. Ophthalmol. 3:1964;135-143.
5. Bárány E. H. Relative importance of autonomic nervous tone and structure as determinants of outflow resistance in normal monkey eyes (Cercopithecus ethiops and Macaca irus). Rohen JW. The Structure of the Eye, Second Symposium. 1965;223-236 FK Schattauer Verlag.
6. Bennett J., Wilson J., Sun D., Forbes B., Maguire A. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest. Ophthalmol. Vis. Sci. 35:1994;2535-2542.
7. Bill A. Aqueous humor dynamics in monkeys (Macaca irus and Cercopithecus ethiops). Exp. Eye Res. 11:1971;195-206.
8. Bito L. Z. Species differences in the response of the eye to irritation and trauma: a hypothesis of divergence in ocular defense mechanisms, and the choice of the experimental animals for eye research. Exp. Eye Res. 39:1984;807-829.
9. Borrás T., Tamm E. R., Zigler J. Jr. Adenovirus gene transfer varies in efficiency and inflammatory response. Invest. Ophthalmol. Vis. Sci. 37:1996;1282-1293.
10. Borrás T., Matsumoto Y., Epstein D. L., Johnson D. H. Gene transfer into human trabecular meshwork by anterior segment perfusion. Invest. Ophthalmol. Vis. Sci. 39:1998;1503-1507.
11. Brandt C. R., Kintner R. L., Pumfery A. M., Visalli R. J., Grau D. R. The herpes simplex virus ribonucleotide reductase is require for ocular virulence. J. Gen. Virol. 72:1991;2043-2049.
12. Brandt C. R., Imesch P., Spencer B. J., Eliassi-Rad B., Syed N. A., Untawale S., Robinson N. L., Albert D. M. The herpes simplex virus type 1 ribonucleotide reductase is required for acute retinal disease. Arch. Virol. 142:1997;883-896.
13. Breakefield X. O., Deluca N. A. Herpes simplex virus for gene delivery to neurons. New Biologist. 11:1991;203-218.
14. Budenz D. L., Bennett J., Alonso L., Maguire A. In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 36:1995;2211-2215.
15. Cameron J. M., McDougall I., Marsden H. S., Preston V. G., Ryan D. M., Subak-Sharpe J. H. Ribonucleotide reductase encoded by herpes simplex virus is a determinant of the pathogenicity of the virus in mice and a valid antiviral target. J. Gen. Virol. 69:1988;2607-2612.
16. Cayouette M., Gravel C. Adenovirus-mediated gene transfer to retinal ganglion cells. Invest. Ophthalmol. Vis. Sci. 37:1996;2022-2028.
17. Chen, Z., Jia, W. and Cynader, M. (1997). Herpes simplex virus-mediated LacZ gene transfer into rabbit retina. Invest. Ophthalmol. Vis. Sci. (ARVO Abstract) 38, s1133.
18. Deluca N. A., McCarthy A. M., Schaffer P. A. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J. Virol. 56:1985;558-570.
19. Dull T., Zufferey R., Kelly M., Mandel R. J., Nguyen M., Trono D., Naldini L. A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72:1998;8463-8471.
20. Ferrari F. K., Xiao X., McCarty D., Samulski R. J. New developments in the generation of Ad-free, high-titer rAAV gene therapy vectors. Nat Med. 3:1997;1295-1297.
21. Flannery J. G., Zolotukhin S., Vaquero M. I., LaVail M. M., Muzyczka N., Hauswirth W. W. Efficient photoreceptor-targeted gene expression in vivo by recombinant adeno-associated virus. Proc. Natl. Acad. Sci. USA. 94:1997;6916-6921.
22. 2αincreases uveoscleral outflow in the cynomolgus monkey. Exp. Eye Res. 49:1989;389-402.
23. Glorioso J. C., Bender M. A., Goins W. F., Fink D. J., Deluca N. HSV as a gene transfer vector the nervous system. Mol. Biotechnol. 4:1995;87-99.
24. Goldstein D. J., Weller S. K. Factor (s) present in the herpes simplex virus type-1-infected cells can compensate for the loss of the large subunit of the virus ribonucleotide reductase: characterization of an ICP6 deletion mutant. Virology. 166:1988;41-51.
25. Grau D. R., Visalli R. J., Brandt C. R. Herpes simplex virus stromal keratitis is not titer-dependent and does not correlate with neurovirulence. Invest. Ophthalmol. Vis. Sci. 30:1989;2474-2480.
26. Herold B. C., Visalli R. J., Susmarski N., Brandt C. R., Spear P. G. Glycoprotein C-independent binding of herpes simplex virus to cells requires cell surface heparin sulfate and glycoprotein B. J. Gen. Virol. 75:1994;1211-1222.
27. Huard J., Feero W. G., Watkins S. C., Hoffman E. P., Rosenblatt D. J., Glorioso J. C. The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers. J. Virol. 70:1996;8117-8123.
28. Huard J., Krisky D., Oligino T., Marconi P., Day C. S., Watkins S. C., Glorioso J. C. Gene transfer to muscle using herpes simplex virus-based vectors. Neuromuscular Disorders. 7:1997;299-313.
29. Idowu A. D., Fraser-Smith E. B., Poffenberger K. L., Herman R. C. Deletion of the herpes simplex virus type-1 ribonucleotide reductase gene alters virulence and latency in vivo. Antiviral Res. 17:1992;145-156.
30. Jacobson J. G., Leib D. A., Goldstein D. J., Bogard C. L., Schaffer P. A., Weller S. K., Coen D. M. A herpes simplex virus ribonucleotide reductase deletion mutant is defective for productive acute and reactivatable latent infections of mice and for replication in mouse cells. Virology. 173:1989;276-283.
31. Johnson P. A., Miyanohara A., Levine F., Cahill T., Friedmann T. Cytotoxicity of a replication-defective mutant of herpes simplex virus type 1. J. Virol. 66:1992;2952-2965.
32. Johnson P. A., Wang M. J., Friedmann T. Improved cell survival by the reduction of immediate-early gene expression in replication-defective mutants of herpes simplex virus type 1 but not by mutation of the virion host shutoff function. J. Virol. 68:1994;6347-6362.
33. Jomary C., Piper T. A., Dickson G., Couture L. A., Smith A. E., Neal M. J., Jones S. E. Adenovirus-mediated gene transfer to murine retinal cells in vitro and in vivo. FEBS Lett. 347:1994;117-122.
34. Kaufman P. L., Jia W. W. G., Tan J., Chen Z., Gabelt B. T., Booth V., Tufaro F., Cynader M. A perspective of gene therapy in the glaucomas. Surv. Ophthalmol. 1999;In press.
35. Li T., Breakefield X. O., Garber D., Knipe D., Roof D., Mukai S., Berson E. L., Dryja T. P. Evaluation of derivatives of herpes simplex virus type 1 (HSV-1) as potential vectors for gene therapy of the neural retina and the retinal pigment epithelium. Invest. Ophthalmol. Vis. Sci. (ARVO Abstract). 34:1993;1370.
36. Li T., Davidson B. L. Phenotype correction in retinal pigment epithelium in murine mucopolysaccharidosis VII by adenovirus-mediated gene transfer. Proc. Nat. Acad. Sci. USA. 92:1995;7700-7704.
37. Li T., Adamian M., Roof D. J., Berson E. L., Dryja T. P., Roessler B. J., Davidson B. L. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest. Ophthalmol. Vis. Sci. 35:1994;2543-2549.
38. 2αin human ciliary smooth muscle cells. Invest. Ophthalmol. Vis. Sci. 35:1994;242-250.
39. Mineta T., Rabkin S. D., Yazaki T., Hunter W. D., Martuza R. L. Attenuated multi-mutated herpes simplex virus-1 for the treatment of malignant gliomas. Nature Medicine. 1:1995;938-943.
40. Nickells R. W. Retinal ganglion cell death in glaucoma: the how, the why, and the maybe. J. Glaucoma. 5:1996;345-356.
41. Pepose J. S., Leib D. Herpes simplex viral vectors for therapeutic gene transfer delivery to ocular tissues. Recent breakthroughs in the molecular genetics of ocular diseases. Invest. Ophthalmol. Vis. Sci. 35:1994;2662-2666.
42. Polansky J. R., Wood I., Maglio M. T., Alvarado J. A. Trabecular meshwork cell culture in glaucoma research: Evaluation of biological activity and structural properties of human trabecular cells in vitro. Ophthalmology. 91:1984;580-595.
43. Reichel M. B., Ali R. R., Hunt D. M., Bhattacharya S. S. Gene therapy for retinal degeneration. Ophthalmic. Res. 29:1997;261-268.
44. Rohen J. W. The evaluation of the primate eye in relation to the problems in glaucoma. Lütjen-Drecoll E. Basic Aspects of Glaucoma Research. 1982;3-33 Schattauer.
45. Rohen J. W. The histologic structure of the chamber angle in primates. Am. J. Ophthalmol. 52:1961;529.
46. Smith F., Jacoby D., Breakefield X. O. Virus vectors for gene delivery to nervous system. Resto, Neuro. Neurosci. 8:1995;21-34.
47. Thelander L., Reichard P. Reduction of ribonucleotides. Ann. Rev. Biochem. 48:1979;133-158.
48. Visalli R. J., Brandt C. R. The HSV-1 UL45 18 kDa gene product is a true late protein and a component of the virion. Virus Res. 29:1993;167-178.
49. Wu N., Watkins S. C., Schaffer P. A., DeLuca N. A. Prolonged gene expression and cell survival after infection by a herpes simplex virus mutant defective in the immediate-early genes encoding ICP4, ICP27, and ICP22. J. Virol. 70:1996;6358-6369.
50. Yamada Y., Kimura H., Morishima T., Daikodu T., Maeno K., Michiyama Y. The pathogenicity of ribonucleotide reductase-null mutants of herpes simplex virus type 1 in mice. J. Infect. Dis. 164:1991;1091-1097.